Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma
Sign Up to like & getrecommendations! Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s354291
Abstract: Purpose Janus kinase 1 (JAK1) is implicated in multiple inflammatory pathways that are critical for the pathogenesis of asthma, including the interleukin (IL)-4, IL-5, IL-13, and thymic stromal lymphopoietin cytokine signaling pathways, which have previously… read more here.
Keywords: azd0449 azd4604; jak1; lung; jak1 inhibitors ... See more keywords